Ilona Kocáková
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Colorectal and Anal Carcinomas, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology, Colorectal Cancer Surgical Treatments
Most-Cited Works
- → Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer(2013)2,231 cited
- → Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study(2010)1,795 cited
- → Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer(2014)599 cited
- → Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)(2012)206 cited
- → MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients(2012)124 cited
- → Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial(2014)113 cited
- → Analysis of KRAS/NRAS and BRAF mutations in the phase III PRIME study of panitumumab (pmab) plus FOLFOX versus FOLFOX as first-line treatment (tx) for metastatic colorectal cancer (mCRC).(2013)51 cited
- → Randomized, open-label, phase III study of panitumumab (pmab) with FOLFOX4 versus FOLFOX4 alone as first-line treatment (tx) for metastatic colorectal cancer (mCRC): Efficacy by skin toxicity (ST).(2010)19 cited
- Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma.(2007)
- → Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy(2004)14 cited